Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).. Mustafic, H; Fayssoil, A; Josseran, L; Ouadahi, M; Grimaldi-Bensouda, L; Dubourg, O; Annane, D; Mansencal, N. Am J Cardiol. 2021; 147: p.58-60. doi:10.1016/j.amjcard.2021.02.009Article
Echappement aux anti-infectieux et pharmacoépidémiologie